Gastrointestinal therapeutics Market Research Reports

"...... rmaceuticals, Chiesi Farmaceutici, Cosmo Pharmaceuticals, Nippon Shinyaku, Prokarium Limited, Scandinavian Biopharma, Sigmoid Pharma By Application Adult, ChildrenAnti-motility agents, Bismuth Subsalicylate (Pepto-Bismol), Antib......"

"...... Yuekang, Yangtze River Pharm, Ask-pharm, Changzhou Siyao, Takeda, Xian Janssen, Huadong Medicine, Shandong Luoxin, Guangdong Dahua By Application Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD......"

"...... aus Medical, Ardelyx, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio Pharmaceuticals, Zealand Pharma By Application By Type Oral Route, Parental Route The prime objective of this report is to hel......"

"...... ratories, Biocon Ltd, Roche, Johnson and Johnson, Mylan Pharmaceuticals, Novartis AG, Pfizer, Quest Medical, Sanofi, Takeda Pharmaceutical By Application Amino-salicylates, Antibiotics, Corticosteroids, Immunomodulators, Biologi......"

"...... Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria(Tillotts), Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen By Application Chronic Gastritis, Functional Dyspepsia, Peptic Ulcer, Acute Gastro......"

"...... d: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%. ......"

"...... ell as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate ......"

"...... file, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, sales data and product specifications etc.:......"

"...... cture Of The Exocrine Pancreatic Insufficiency Pipeline Landscape Is Provided, Which Includes The Disease Overview And Exocrine Pancreatic Insufficiency Treatment Guidelines. The Assessment Part Of The Report Embraces In-Depth Exocrine......"

"...... ed: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%. ......"